CSI Market
Sign In | Register

Phoenix Biotech Acquisition (PBAXU) Annual Balance Sheets

Annual · GAAP · USD millions
Access PBAXU quarterly Balance Sheets →
This balance sheet overview for Phoenix Biotech Acquisition spans from Dec 31 2021 to Dec 31 2025, showing how the company's assets, liabilities, and equity have evolved across reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent1.70
Marketable Securities0.00
Cash & Short-term Investments1.00
Deferred Costs, Current AS0.50
Other Current Assets0.00
Prepaid Expense And Other Assets Current1.07
Total Current Assets2.73
Equipment/Property/Plant Net0.25
Long-term investments0.00
Tax Assets, Noncurrent23.18
Deferred Costs, Noncurrent AS0.00
Other Assets, Noncurrent0.00
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents3.33
Deferred Tax Asset-
Operating Lease Right Of Use Asset1.46
Total Assets3.64
Liabilities
Accounts Payable, Current AC7.58
Accrued Liabilities, Current AC0.36
Derivative Liability, Current DE0.02
Short-term Bank Loans and Notes Payable SH0.00
Other Liabilities, Current0.00
Accrued Income Taxes, Current TA0.55
Total Current Liabilities9.09
Long-term debt0.00
Total Long-term Debt0.00
Deferred credits, Noncurrent0.00
Other liabilities, Noncurrent0.00
OperatingLeaseLiabilityNoncurrent0.70
Earnout Liability Current-
Operating Lease Liability Current0.88
Total Liabilities9.09
Stockholders' Equity
Accumulated Deficit One-
Common Stock Value0.00
Additional Paid In Capital Common Stock78.13
Retained Earnings / Accumulated Deficit-90.84
Defined Benefit Plan and Other0.00
Other Equity0.00
Common Stockholder's Equity-5.45
Preferred Stockholder's Equity0.00
Non-controlling interests & other0.00
Total Stockholder's Equity-5.45
Liabilities & Stockholder's Equity3.64
4 historic quarters locked

Sign in to unlock the full Phoenix Biotech Acquisition balance sheet history.

Sign In Create Free Account

About Cero Therapeutics Holdings Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-26-044040

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License